Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert G Masterton

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Antimicrobial Agents|December 7, 2010
Antibiotic heterogeneityRobert G Masterton
Critical Care Clinics|December 15, 2010
Antibiotic de-escalationRobert G Masterton
The Journal of Antimicrobial Chemotherapy|December 3, 2004
Antibiotic cycling: more than it might seem?Robert G Masterton
International Journal of Antimicrobial Agents|October 14, 2008
The new treatment paradigm and the role of carbapenemsRobert G Masterton
Intensive Care Medicine|March 25, 2009
Sepsis care bundles and cliniciansRobert G Masterton
The Journal of Antimicrobial Chemotherapy|July 12, 2007
Improving practice--the Hospital Pharmacy Initiative revisitedRobert G Masterton, Michele Caldwell
British Journal of Hospital Medicine (London, England : 2005)|September 21, 2010
Approaches to improving antibiotic managementRobert G Masterton, Craig Williams
International Journal of Antimicrobial Agents|December 14, 2005
Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997-2002)Robert G Masterton, Philip J Turner
Intensive Care Medicine|December 7, 2013
The case for de-escalation in antimicrobial therapy: time to change our strategy in the management of septic shock?Matteo Bassetti, José-Artur Paiva, Robert G Masterton
The Journal of Antimicrobial Chemotherapy|December 3, 2004
The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in EuropeRobert G Masterton, Joseph L Kuti, Philip J Turner, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Antimicrobial Agents|December 7, 2010
Antibiotic heterogeneityRobert G Masterton
Critical Care Clinics|December 15, 2010
Antibiotic de-escalationRobert G Masterton
The Journal of Antimicrobial Chemotherapy|December 3, 2004
Antibiotic cycling: more than it might seem?Robert G Masterton
International Journal of Antimicrobial Agents|October 14, 2008
The new treatment paradigm and the role of carbapenemsRobert G Masterton
Intensive Care Medicine|March 25, 2009
Sepsis care bundles and cliniciansRobert G Masterton
The Journal of Antimicrobial Chemotherapy|July 12, 2007
Improving practice--the Hospital Pharmacy Initiative revisitedRobert G Masterton, Michele Caldwell
British Journal of Hospital Medicine (London, England : 2005)|September 21, 2010
Approaches to improving antibiotic managementRobert G Masterton, Craig Williams
International Journal of Antimicrobial Agents|December 14, 2005
Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997-2002)Robert G Masterton, Philip J Turner
Intensive Care Medicine|December 7, 2013
The case for de-escalation in antimicrobial therapy: time to change our strategy in the management of septic shock?Matteo Bassetti, José-Artur Paiva, Robert G Masterton
The Journal of Antimicrobial Chemotherapy|December 3, 2004
The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in EuropeRobert G Masterton, Joseph L Kuti, Philip J Turner, et al.
Pageof 2